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PENGOPTIMUMAN PROGRAM JAMINAN KUALITI (QAP) UNTUK 





Radioterapi adaptif berpandukan imej (IGART) adalah rawatan termaju yang melibatkan 
proses mengubah suai perancangan rawatan dengan mengambil kira perubahan pada isipadu 
tumor sepanjang rawatan. Kajian ini bertujuan untuk mengoptimumkan program jaminan kualiti 
(QAP) terhadap linac yang berkaitan dengan IGART. Linac dikaji dalam penyelidikan ini adalah 
Elekta Synergy yang mempunyai 80 pasang kolimat pelbagai lapisan dinamik (MLC) dan sistem 
berpandu imej tomografi terkomputasi pancaran kon (CBCT). Prestasi linac diukur menggunakan 
QAP yang telah dioptimumkan dari segi penyampaian pengeluaran dos, MLC dinamik dan sistem 
berpandu imej CBCT. Pengeluaran dos linac untuk pancaran 6 MV dan 10 MV diukur setiap hari 
menggunakan alat pengesan dos yang telah ditentuukur iaitu Quickcheck. Parameter yang dinilai 
selama 19 bulan adalah dos pusat, kesamarataan, kesimetrian dan kualiti pancaran. Variasi 
keputusan berada pada julat toleransi iaitu pusat dos ± 2%, kesamarataan pancaran ± 1.5%, 
kesimetrian pancaran ± 3% dan kualiti pancaran ± 3%. Prestasi MLC dinamik dianalisis secara 
mingguan dari segi ketepatan kedudukan kolimat menggunakan sistem pemantaun MLC pada 
Elekta dan disahkan dengan teknik piawai menggunakan EPID. Julat ralat kedudukan MLC dinilai 
dari sistem pemantauan MLC adalah -0.30 mm hingga 0.80 mm, ianya berada dalam julat 
keputusan dari imej EPID. Prestasi sistem berpandu imej CBCT dinilai setiap bulan dari segi 
kualiti imej dan ketetapan nombor CT menggunakan phantom CIRS 062QA yang bersaiz kecil 
dan dibandingkan dengan pengukuran menggunakan phantom Catphan 600. Terdapat variasi 
antara phantom tetapi kedua-duanya mempunyai trend yang sama sepanjang tempoh 6 bulan. 
Variasi wujud disebabkan oleh perbezaan saiz dan reka bentuk phantom. Secara kesimpulan, QAP 
xv 
 
yang telah dioptimumkan adalah lebih cekap kerana memerlukan penyediaan yang lebih mudah 
untuk mengukur beberapa parameter dalam satu masa, keputusan yang diperolehi juga adalah 
sama dengan keputusan daripada teknik piawai QAP. Maka, QAP yang dioptimumkan boleh 
dijalankan secara rutin dan lebih kerap untuk memberikan jaminan keselamatan dalam rawatan 
teknik IGART.   
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OPTIMISATION OF QUALITY ASSURANCE PROGRAMME (QAP) FOR 





Image-guided adaptive radiotherapy (IGART) is an advanced radiotherapy treatment 
technique that involves treatment plan modifications during the treatment course to account for 
temporal changes in tumour volume. The purpose of this study is to develop a Quality Assurance 
Programme (QAP) for a linac that is optimised for IGART. The linac investigated in this study is 
an Elekta Synergy linac with 80 pairs of multileaf collimators (MLC) and cone beam computed 
tomography (CBCT) image guidance system. An optimised QAP was developed to assess relevant 
linac performance parameters including dose output delivery, dynamic MLC and CBCT image 
guidance system. Linac dose output was measured daily using a cross-calibrated detector, 
Quickcheck. The parameters evaluated were central dose output, beam flatness, beam symmetry 
and beam quality for a period of 19 months. The variations of measurement were within the 
tolerance level. The central dose outputs are within ± 2%, the beam flatness results are within ± 
1.5%, the beam symmetry results are within ± 3% and the beam quality results are within ± 3%. 
The dynamic MLC performance was analysed weekly in term of leaf positional accuracy using 
Elekta’s propriety MLC tracking system that is verified against EPID measurement. The MLC 
position errors tracked were between -0.30 mm to 0.80 mm, within the range of the results from 
EPID. The performance of CBCT image guidance system was assessed monthly in term of image 
quality and CT number accuracy using smaller sized CIRS 062QA and compared against the more 
commonly used Catphan 600. The interphantom variations were observed in the measured 
parameters, yet they have similar trend to each other. The variations exist due to the difference in 
the size and geometric design of the phantoms. In conclusion, the optimised QAP developed was 
xvii 
 
more efficient that provides a simpler setup procedure for multiple measurement and semi-
automated analysis, but also agreed with the results obtained using standard QAP method. Thus, 




CHAPTER 1 INTRODUCTION 
 
1.1   Introduction to modern radiotherapy 
 
Malaysian National Cancer Registry Report (MNCR) reported a total of 103507 new cancer cases 
diagnosed in Malaysia during the period of 2007 to 2011 (Zainal & Nor Saleha, 2011). 
Radiotherapy is one of the most common types of cancer treatment, either as a standalone 
treatment or in combination with chemotherapy and/or surgery. Radiotherapy is used for the 
treatment of malignant tumours and plays an important part in cancer cure by delivering ionising 
radiation.  
The main goal of radiotherapy is to deliver radiation dose to the tumour whilst minimising 
the dose to normal tissue. Radiation traverses through the body to reach cancerous tissue. Some 
normal tissues are exposed to the radiation with magnitude depending on the type and the amount 
of radiation. This is described by the tumour control probability (TCP) and normal tissue 
complication probability (NTCP) curves illustrated in Figure 1.1. TCP is shown by curve A, while 
NTCP is shown by curve B and the green shaded region illustrates the therapeutic window, which 
highlights a range of doses for which there is an acceptable balance between the probability of 
cure and the risk of excessive toxicity. Increasing the dose beyond this range improves local 
control, but at the cost of increasing the risk of normal tissue complications. Hence, conformal 
treatment plans are required to obtain the highest curative probability and at the same time the 




Figure 1.1 Illustration of TCP and NTCP as a function of dose. Curve A represents TCP, curve 
B represents NTCP, and the therapeutic window is illustrated by the green shaded region 
(Rosenberg, 2008) 
 
Recent advances in radiotherapy technology has allowed delivery of more conformal 
radiation to achieve the aim of radiotherapy. This will be addressed in the subsequent sections. 
Section 1.1.1 will explain current treatment techniques using intensity modulated radiotherapy 
(IMRT) and image guided radiotherapy (IGRT) and Section 1.1.2 will describe image-guided 
adaptive radiotherapy (IGART) technique. 
 
1.1.1   IMRT and IGRT techniques 
 
IMRT is a sophisticated treatment technique widely used today, with a complex treatment chain 
to enable delivery of highly conformal beam dose to the patients. The basic principle of IMRT is 
to use modulated beam intensities to vary the dose delivery and irradiating the tissue from different 
directions to maximise dose at beam intersections. IMRT improves target coverage and organ at 
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risk (OAR) sparing compared to conventional three dimensional conformal radiotherapy 
(3DCRT) treatment technique (Van Dieren et al., 2000; Xia et al., 2000).  
3DCRT is based on 3D anatomic information such that resulted dose distribution 
conforms to the target volume closely in term of adequate dose to the tumour and minimal dose 
to the normal tissues. The treatment plan in 3DCRT is manually optimised to obtain the desired 
dose distribution. The beam parameters such as number of beams, beam directions, beam shapes, 
wedges and weightages are set, then the computer calculates the resulting dose distribution. For 
IMRT treatment plan, it is the other way around, where the physicist only has to decide the desired 
dose distributions and some of the treatment parameters. The rest of the treatment parameters are 
calculated by the computerised treatment planning system. The radiation intensity in 3DCRT is 
uniform within each beam, whilst modulated in IMRT. The principles of 3DCRT and IMRT 
treatment technique is illustrated in Figure 1.2 (a) and (b), respectively.  
 In IMRT, target volumes and organ at risks (OARs) are delineated following the 
recommendations by ICRU Report 62 (ICRU, 1999), as shown in Figure 1.3. The target volumes 
to be considered while delineating are the gross tumour volume (GTV), clinical tumour volume 
(CTV), internal target volume (ITV) and planning target volume (PTV). GTV is contoured based 
on the gross radiologically visible tumour during treatment planning. Then other target volumes 
are expanded relative to GTV. CTV is a volume of tissue that contains GTV and/or subclinical 
malignant diseases, ITV is the uncertainties of CTV due to the internal organ motion, and PTV is 
a geometrical extension of CTV to account for all geometrical variations and inaccuracies. The 
OARs are the normal tissues surrounding the target volume that are critical structures to be spared 





Figure 1.2 Illustration of (a) 3DCRT and (b) IMRT principle. Image taken from Schlegel et al. 
(Schlegel & Mahr, 2007)  
 
 
Figure 1.3 Schematic diagram of target volumes delineation recommended by ICRU Report 62 
(ICRU, 1999) 
 
There are many studies performed to demonstrate how IMRT can improve tumour 
irradiation while sparing the surrounding normal tissues (Jin et al., 2009; Zhang et al., 2013). Lee 
et al. has studied the impact of IMRT field in the treatment of 67 patients for nasopharyngeal 
carcinoma (NPC) cancer. The patients were followed-up over 7 to 72 months for physical 
 
        (a)                 (b) 
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examination, and obtained the baseline post-treatment MRI scan and positron emission 
tomography (PET) scan of the nasopharynx and neck. They found that IMRT provides excellent 
tumour target coverage and allowed the delivery of a high dose to the target with significant 
sparing of the salivary glands and other nearby critical normal tissues (Lee et al., 2002). 
The highly conformal IMRT dose distributions are more sensitive to misalignments of the 
target with respect to the planned dose. Geometric uncertainties may arise that can affect the 
accuracy and precision of IMRT treatment (Dawson & Sharpe, 2006). The geometrical 
uncertainties can occur in term of patient setup and organ motions. The steep dose gradients from 
the IMRT treatment particularly are very sensitive to the patient position errors and anatomic 
changes. Small changes in anatomic of the patient can result in under-dosing the target volumes 
and overdosing the healthy tissues, which may translate into compromised tumour control and/or 
increased adverse effects (Wu et al., 2011). 
Minimising these uncertainties by guidance from on board imaging system can improve 
IMRT treatment delivery. The common image-guidance used are electronic portal device (EPID) 
and cone-beam computed tomography (CBCT). This process is known as image guided 
radiotherapy (IGRT) that can be defined as the use of frequent imaging in the treatment room prior 
to the beam delivery. The development of IGRT enables imaging of the tumour before IMRT 
treatment delivery. The treatment position is verified based on the position on-treatment image 
relative to the CT scan image thus enable reduction of errors that could occur during treatment. 
The patient setup error is corrected based on the acquired images. Nabavizadeh et al. has done a 
survey regarding the practice of IGRT on radiotherapy workflow. Out of 601 respondents of 
American Society of Radiation Oncology (ASTRO), 95% reported IGRT use in the radiotherapy 
workflow and also 92% of them used CBCT imaging for all treatment sites except breast cancer 




1.1.2   IGART framework to overcome limitations in IG-IMRT  
 
The accuracy and precision of IMRT treatment delivery can be improved by IGRT. However, one 
of the main limitations in IGRT is the way that anatomical changes are dealt with. Several 
researchers have investigated the changes occurred during the course of treatment. Barker et al. 
reported the changes in GTV in the head and neck cancer over the course of radiotherapy by 
obtaining three CT scans per week for 14 patients. The GTV decreased throughout the course of 
treatment at a median rate of 0.2 cm3 per treatment day, resulting in a median total GTV loss of 
70% of the first fraction (Barker et al., 2004). Besides, Wang et al. studied an average volume loss 
of 20% at parotid glands after three weeks treatment (Wang et al., 2009).  
IGRT technique relies on initial imaging radiotherapy simulation and treatment planning, 
and the following fractions only required correction of patient positioning before dose delivery 
(Xing et al., 2011). In fact, the changes either in size, shape or position of the tumour or OARs 
since the initial planning CT cannot be corrected only by patient positioning and/or treatment 
couch shifts (Schwartz, 2012), unless adapting treatment plan during the course of treatment 
(Mohan et al., 2005).  
Image guided adaptive radiotherapy (IGART) was first introduced by Yan et al., which is 
an approach to correct for daily and normal tissue variations through modification of original 
treatment plan during the course of treatment (Yan et al., 1997). There are several researchers that 
have investigated the benefit of IGART in clinical implementation. Nijkamp et al. has studied the 
first clinical implementation of IGART for 20 prostate patients using CBCT imaging. The 
irradiated target volume safely reduced by 29% and thus lead to a significant reduction in the dose 
to the rectum (Nijkamp et al., 2008). Clinical benefit of re-planning was also assessed by Jensen 
et al., where adaptive radiotherapy in IMRT of head and neck tumours have been conducted for 
15 patients. The results showed that re-planning during the course of IMRT treatment maintains 
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adequate coverage of the target volumes and allows parotid gland sparing (Jensen et al., 2012). A 
recent study by Keall et al. treated eight prostate patients using IGART treatment technique. They 
found that the dose distribution from IGART is closer to the planned dose than without IGART. 
For the largest motion fraction, CTV received 100% of the prescribed dose with IGART treatment, 
meanwhile, CTV only received 95% of the prescribed dose without IGART (Keall et al., 2018). 
Moreover, Allen et al. also proved that the use of IGART strategy on patients treated with IMRT 
for head and neck cancer reduced the incidence of high-grade skin toxicity and mucositis in the 
acute setting (Chen et al., 2017).   
IGART approaches break the conventional sequential procedure of radiotherapy 
simulation, treatment planning, patient shift (after position verification) and dose delivery as 
illustrated in Figure 1.4. IGART involves dose distribution and imaging assessment throughout 
the course of treatment to determine the needs of plan modification prior to treatment delivery 
(Xing et al., 2011). The decision on treatment plan modification is based on the anatomical 
changes measured from the on-board imaging system. The initial treatment plan is modified when 
anatomical changes alter the dose distribution to the extent that treatment planning criteria are no 
longer met by under-dosage of the target volumes and/or over-dosage the OARs. 
Theoretically, IGART can be performed in three different timescales: offline between 
fractions, online immediately prior to a fraction or real time during the fraction. The offline 
technique involves delivering future treatment fraction from the adaptation of treatment plan based 
on the previous fraction. Meanwhile, the online technique involves adapting treatment plan based 
on image acquired from the current fraction. Lastly, real time technique involves continually 
updating the treatment based on images obtained simultaneously with treatment, such as the target 
tumour occurs in the chest or abdomen which affected by respiratory or other source of intra-




Figure 1.4 IGRT process (top) and IGART process (bottom) (Timmerman & Xing, 2012) 
 
1.2   Quality assurance programme (QAP) 
 
Advances in IMRT and IGRT delivery technologies throughout the last decade have made it 
possible to deliver highly conformal plan by modulating the beam intensity to adapt the changes 
on the tumour target using IGART. Therefore, robust quality assurance programme (QAP) is 
required to ensure the consistency of machine performance from the time of commissioning and 
customer acceptance testing (CAT) (Nath et al., 1994). There are several international 
recommendations on procedures and conditions for commissioning and CAT, such as from The 
International Electrotechnical Commission (IEC), American Association of Physicists in 
Medicine (AAPM), and American of College of Medical Physics (ACMP). The machine 
parameters obtained from the commissioning and CAT were set as baseline. The deviation of 
machine parameters from the baseline could affect the accuracy of radiotherapy treatment. The 
malfunctioning of the machine, mechanical breakdown, physical accidents, and hardware or 
component replacement may cause the deviation of machine parameters. According to World 
Health Organisation (WHO), QAP for radiotherapy is to minimise errors in treatment delivery and 
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thereby improves the results of therapy by increasing remission rates and decreasing complication 
and recurrence rates (World Health Organisation, 1988). 
The guidelines for QAP for radiotherapy are mainly based on the national and 
international recommendations such as IEC, AAPM, IAEA and Institute of Physics and 
Engineering in Medicine (IPEM). Some of the guidelines described recommendation on test 
procedure, test frequencies and the tolerance level. 
 The technology of linac is rapidly evolving to assure the IGART delivery is precise and 
accurate. Hence, the QAP also need to be improved as the treatment will become more 
sophisticated. The delivery parameters must be accurately delivered and should be routinely 
monitored. For example, there were evolutions of recommendations of QAP for radiotherapy in 
the AAPM report. The recommendations started from the task group (TG)-13 (Baily et al., 1994), 
TG-40 (Kutcher et al., 1994), and the latest is TG-142 (Klein et al., 2009). TG-40 supersedes the 
recommendations of TG-13 and also TG-142 updated the recommendations of TG-40 report on 
quality assurance and added recommendations for the new ancillary delivery technologies in the 
linac, such as asymmetric jaws, multileaf collimation (MLC), dynamic/virtual wedges. TG-142 
accomplished the update of TG-40 by specifying new tests, frequency of the tests, and the 
tolerances level. TG-142 also includes guidance that should be taken for the physicists to 
implement particular actions based on the tolerance level, whether they are inspection action, 
scheduled action or immediate stop treatment action. 
 TG-142 also described basic recommendation guidelines on test and tolerance for on 
board image-guidance system performance. AAPM TG-179 has updated TG-142 in providing 
comprehensive guidelines of QAP for commercial available of CT-based IGRT (Bissonnette et 
al., 2012). Recently, European Federation of Organisations For Medical Physics (EFOMP) in 
cooperation with IAEA and European Society for Radiotherapy and Oncology (ESTRO) have 
prepared a comprehensive guidelines to assess the image quality and radiation output in all types 
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of CBCT imaging system (Gala et al., 2017a). The report consists of detailed procedures of the 
image quality tests, the action levels and frequency of the tests. 
Tests and measurements of the machine parameters must be performed periodically to 
ensure the mechanical, geometrical, dosimetry, image quality and general safety of the machine 
is maintained throughout use. The QAP is divided to daily, weekly, monthly and annually that 
cover all aspects of the machine performance tests. The daily tests are performed every morning 
to ensure daily optimum linac output. Monthly tests that is more complicated and often time 
consuming are an expansion of the basic daily check to include dosimetry, mechanical and 
multileaf collimator (MLC) performance of the linac and also the performance of image guidance 
system. Annual tests are typically subset of the tests performed during commissioning and CAT.  
 
1.3   Challenges of QAP for IGART 
 
IGART has become increasing popular radiotherapy treatment technique over the last two 
decades. Implementation of IGART in the clinical practice requires high levels of automation in 
term of image acquisition, registration, treatment dose construction, and adaptive planning 
optimisation. The increased complexity of IGART technique might create an environment in 
which treatment errors are prone to occur and QAP should be also improved and efficiently 
implemented (Yan, 2008). There are many literatures including articles, reports, and books that 
discussed the routine QA tests for IMRT and IGRT treatment. However, to the best of author’s 
knowledge, the QAP specifically optimised for IGART treatment have not been addressed in detail 
in the literatures, except Yan and Wu et al. that have only defined the technical components of 
IGART treatment, such as image guidance, dose verification and treatment adaptation without 
recommendation of optimised protocols to improve the QAP efficiency  (Wu et al., 2011; Yan, 
2008). Therefore, this study aims to develop an optimised QAP based on the existing QA test 
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recommendations that are relevant for IGART treatment. The components involved will be further 
elaborated in Section 2.2. 
 
1.4   Objectives of the study 
 
The main objective of the study is to develop an optimised QAP for IGART. Two sub-objectives 
are as follows. 
• To measure the radiotherapy machine parameters essentials for IGART  
• To develop an optimised QAP for implementation of IGART  
 
1.5 Significance of the study 
 
Robust QAP plays an important role to ensure that the linear accelerator performance is within the 
specifications measured at the time of commissioning and customer acceptance testing. 
Development of a QAP specifically optimised for IGART treatment is necessary in order to have 
a safe treatment delivery of the complex IGART treatment to the patient. Besides, busy clinic and 
heavy workloads of the physicist justify the need for more efficient and reliable approaches to 
QAP but at the same time can measure the machine performance accurately and precisely over the 
time. Optimised QAP developed from this study is expected to be able to reduce the workloads 
by performing simpler QAP procedure and at the same time increase the confidence of IGART 





1.6 Thesis outline 
 
This chapter has briefly explored the motivation of this work and has highlighted the need for 
development of QAP specifically optimised for complex IGART treatment delivery. Further 
details will be described in the next chapters. Chapter 2 explains the equipment of advanced 
radiotherapy system. This chapter also presents a review of literatures describing the components 
of QAP relevant for IGART treatment. Next, Chapter 3 describes the specifications of linac system 
investigated in this study. The equipment used and methods of performing the optimised QA 
procedure of the linac system will be demonstrated in this chapter. Chapter 4 presents the results 
of the QA described in Chapter 3. Chapter 5 summarises the optimised QAP for a linac that is 
relevant to ensure accurate delivery of IGART treatment. The recommendation for the future work 




CHAPTER 2 LITERATURE REVIEW 
 
2.1   Radiotherapy equipment 
 
Radiotherapy is delivered using a linac. Advanced radiotherapy system includes on-board imaging 
system that is integrated on the linac. Figure 2.1 shows the typical assembly of a linac with on 
board imaging system. A linac consists of a rotating gantry, a gantry head, a movable treatment 
couch, a CBCT imaging system (kV source tube and kV flat panel) and an electronic portal device 
(EPID). Section 2.1.1 will explain the main components of a linac. Section 2.1.2 and 2.1.3 will 
explain the on-board imaging systems. 
  





2.1.1   Components of a linac 
 
High energy photon beams are generated from the linac as shown in Figure 2.2. Major components 
of a linac are the rotating gantry and the gantry head as illustrated in the figure. A power supply 
provides direct current (DC) power to the modulator. The pulsed modulator has a pulse forming 
network that converts the continuous electrical energy into pulse form. The pulses are 
simultaneously delivered to the magnetron and the electron gun. The injection of pulses into the 
magnetron causes the production of pulsed electromagnetic waves that are then injected into the 
accelerating waveguide. While, the injection of pulses into the electron gun resulting in a pulsed 
stream of electrons also entering the accelerating waveguide. 
 
Figure 2.2 Block diagram of the linac and rotating gantry head. Diagram also shows the 




The tungsten filament cathode in the electron gun that is heated when voltage is applied. 
The electrons are then ejected from the filament. The heat applied on the filament controlled the 
number of ejected electrons. The electrons injected into the accelerating waveguide and interact 
with the pulsed electromagnetic waves then produced high energy electrons. The electron beams 
exit the accelerating waveguide and enter the bending magnet region that caused the electron 
beams to bend. This process ensure the electron beams strike the tungsten target and focuses to a 
diameter of 1 mm. 
 The photon beam is first collimated by a fixed primary collimator located below the 
tungsten target. The collimated beam then passes through the flattening filter that is responsible 
to modify narrow beam and creates a uniform beam at the isocentre into a clinically useful beam 
through a combination of attenuation at the centre of the beams and scatter at the periphery of the 
beam. The flattened beam will pass through dual ion chambers located below the filtering filter to 
monitor the integrated dose, dose rate and beam quality of the beam. The ion chambers are sealed 
to prevent the external interference such as temperature, pressure and humidity of the outside air 
could influence their response. The dose is measured in monitor unit (MU), which depends on the 
reference dose rate usually 1.0 cGy/MU at a linac calibration point (Almond et al., 1999). The ion 
chamber also monitors the beam characteristics and the dose delivered. The linac will stop the 
beam delivery if the beam characteristics exceeded the acceptance level or the dose has been 
delivered as prescribed. Below the ion chamber, there is a motorised wedge that has a thick and a 
thin ends. The thin end causes less attenuation than the thick end. The wedge function is to shift 
the isodose curve within the treated volume if necessary based on the desired dose distribution. 
 The beams are shaped by another set of collimators to deliver a more conformal beam to 
the tumour. A conventional linac shapes the beam by a set of dense metal collimators built in the 
machine, known as jaws. These collimator jaws are frequently used with the secondary customised 
beam blocks that are attached to the linac below the collimator jaws for beam shaping purposes. 
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The fabricated blocks have a range of shapes and sizes for a given field applied to a specific 
patient. However, the conventional method restricts the conformity of the beam as it only allows 
limited number of beam shape. Multileaf collimator (MLC) has now replaced the beam blocks for 
shaping the beam. MLC is composed of movable leaves that can drive automatically and 
independent of each other to generate a field of any shape and size. The design and operating 
principles of MLC will be further explained in Section 3.2.1. 
 
2.1.2   Electronic portal device (EPID) 
 
Historically, megavoltage (MV) images have been acquired with radiographic film designed 
specifically for portal imaging. Film has long been considered the gold standard in imaging, 
offering high resolution and provide adequate image quality for radiotherapy information. 
However, there are several limitations that lead to the replacing of film for treatment imaging, 
such as time consuming film exposure and development time. The delay makes the portal film 
imaging impractical during the treatment, in which the information is no longer valid due to patient 
movement or internal organ motion. In the last few decades, the EPID has started to become more 
widely available and replacing the films for a faster verification purpose (Herman et al., 2001).  
EPID is mounted on the gantry opposite the treatment head to allow acquisition of images 
of the beam delivery. EPID has been used for patient positioning verification during the treatment 
and used as quality assurance tool to check the several radiotherapy linac parameters such as MLC 
positional accuracy. 
The current generation of EPID is known as amorphous silicon (a-Si) array detector. The 
array detector is comprised of a thin metal plate (typically copper) which acts as build up for the 
primary beam and filters for low energy scattered photon and electrons, a phosphor screen (such 
as terbium-doped gadolinium oxysulfide, Gd2O2S:Tb (Gadox)) to convert x-rays into lights, a light 
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sensor (such as a-Si photodiode) to detect the light and the associated readout electronics. The 
schematic drawing of components in an a-Si EPID system is shown in Figure 2.3. The main 
principle of an a-Si EPID is based on two step processes. In the first step, the incident x-rays are 
converted into optical photons by means of metal plate and the phosphor screen. In the second 
step, the generated photons are absorbed by the a-Si photodiode which create electrical signal 
(Blake et al., 2013).  
 
Figure 2.3 Schematic diagram of cross-section of an a-Si EPID (Blake et al., 2013) 
 
2.1.3   CBCT imaging system 
 
The CBCT imaging system consists of a kilovoltage x-ray tube and a flat panel detector. The x-
ray tube is a glass enveloped containing a cathode assembly (negative electrode) and an anode 
assembly (positive electrode).  Figure 2.4 shows a schematic illustration of the components an x-
ray tube that is connected to power supply. The tungsten filament ejects electrons when it is heated 
by passing through an electric current. A cloud of electrons will form around the filament as it is 




Figure 2.4 X-ray tube and its power supply (Bushberg et al., 2011) 
 
The x-ray tube current (mA) is determined by the number of accelerated electrons per 
second, which is 1 mA equal to 6.24 × 1015 electrons/sec (Bushberg, et al., 2011). Moreover, the 
amount of energy gained by the electrons is determined by the potential difference between 
cathode and anode. For example, the energy of electron with applied potential of 120 kV will 
reach the anode at 120 keV. The maximum energy gained by electron can be defined by peak 
voltage (kVp). The number of accelerating electrons from cathode to the anode increase 
proportionally to the tube current (mA) as well as the exposure time (s). Changing both parameters 
will alter the number of x-ray beams produced at a specific energy. 
The vacuum between cathode and anode, maintained by the enveloped, and the high 
potential difference applied across the cathode and anode (20 to 150 kV), enabling electrons to be 
accelerated with a velocity of around half of the speed of light from cathode and collide at the 
target area of the anode. The collision produced the x-rays. There are two type of x-rays produced: 
bremsstrahlung and characteristic x-rays. A typical x-ray spectrum of both types of x-rays are 
19 
 
shown in Figure 2.5. The Coulumb interactions between the incident electrons and the target nuclei 
of the anode results in continuous x-rays radiation called bremsstrahlung x-rays. This type of 
radiation covers the entire range of the energy spectrum and is the dominant x-ray production 
process (Kruth et al., 2011).  Meanwhile, the characteristic x-rays is produced as a result of 
collision between incident electrons with an orbital electron of the anode. The collision caused 
both electrons to be ejected from the target atom leaving a hole in the inner shell. The vacancy 
causes electron from the outer shell to occupy the inner shell. As a result, an x-ray of discrete with 
energy that is equal to the difference in the binding energies of the two electron shells is emitted. 
This characteristic x-ray is a property of the target material. 
 
Figure 2.5 Typical x-ray spectra (Bushberg et al., 2011) 
 
The x-ray beam produced a cone shaped beam, which can be filtered and reshaped by 
using different types of filters and collimator (Bushberg et al., 2011; Carlton et al., 2013). The 
filters and collimators used in this project will be further explained in the Section 3.2.2. The x-ray 
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beams travel through a patient. The x-ray beams which are not absorbed by the target are differ in 
the x-ray intensity, which is dependent upon the area where they pass through. These variations 
in the intensity will be detected by the image receptor and create radiographic images. The image 
receptor is commonly a flat panel detector (FPD) that are generally composed of an a-Si array 
detector and a scintillator. The process of x-rays beam detection and image construction similar 
in the EPID.   
 
2.2   Components of QAP for IGART 
 
The goal of IGART is to optimise the ratio of normal tissue sparing and target coverage by 
adapting treatment plan throughout the treatment course. There are three main components in the 
implementation of IGART treatment: dose verification, image guidance, and plan adaptation (Wu 
et al., 2011). Therefore, QA tests should be performed and optimised with respect to these 
components: verification of the intensity modulated beam delivery (includes monitoring of linac 
dose output and MLC performance) and the performance of the image guidance system for 
adaptation. Relevant components in QAP for IGART are summarised in Table 2.1. The QA test 
protocols for linac dose output, MLC and image guidance system will be explained in Section 







Table 2.1 Relevant QAP for IGART 
Components Frequency of test Metrices 
Linac dose output Daily • Dose output 
• Beam profile 
• Beam energy 
Monthly • Central dose output 
• Beam energy 
MLC radiation shaping Weekly • MLC positional accuracy 
CBCT image guidance Monthly • Noise and uniformity 
• Contrast: contrast to noise ratio (CNR) 
and low contrast visibility (LCV) 
• Spatial resolution 
• Geometric distortion 
• CT number 
 
2.2.1   Linac dose output 
 
The linac dose output should be measured  daily and monthly in accordance to TG-40 (Kutcher et 
al., 1994) and TG-142 (Klein et al., 2009) recommendations. Typically, a water tank phantom and 
an ionisation chamber (calibrated against secondary standard dosimetry laboratory (SSDL)) are 
used for beam measurement during commissioning as recommended by TG-106 (Das et al., 2008). 
However, the setup is complex and time consuming. Hence, a more simple and efficient setup 
device can be used during the routine measurements of daily and monthly tests. For example, a 
secondary measurement system is used for monthly measurements and tertiary system is used for 
daily measurements as a consistency check. In fact, these systems should be appropriately used 
and calibrated against the absolute standard data (Smith et al., 2017). The absolute data 
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measurement commonly followed AAPM TG-51 (Almond et al., 1999) or IAEA TRS-398 (IAEA, 
2000) recommendations.  
The tolerance levels of linac dose output constancy suggested by AAPM TG-40 and TG-
142 are different based on the test frequencies. For daily measurements, the linac dose output 
should fall within ± 3% of baseline, and for monthly measurements should fall within 2% of 
baseline. Meanwhile, IAEA Report 31 has recommended the linac output constancy uncertainties 
of ± 2% (IAEA, 2016). Besides, survey done by Palmer et al. (Palmer et al., 2012) and Bolt et al. 
(Bolt et al., 2017) to determine current radiotherapy linac quality control practice in many centres 
found that  the allowable range of dose output set by most of the centres is ± 2%. An action to 
correct the linac dose output should be taken if the dose output is outside of the tolerance level to 
bring back to an acceptable level.  
Another important quantity that should be measured to ensure the accuracy and 
reproducibility of dose delivered from the linac is constancy of the beam profile. It is measured in 
term of beam flatness and beam symmetry (Klein et al., 2009; Kutcher et al., 1994). The 
recommendation of tolerance level for  monthly measurements is ± 2% (Klein et al., 2009; Kutcher 
et al., 1994; Smith et al., 2017).The beam energy constancy also plays an important role in 
ensuring the accuracy and reproducibility of dose delivery in radiotherapy. During data 
commissioning, the full depth dose curve in water is measured as percentage depth dose (PDD). 
PDD is an attenuation-based metric which traditionally used to monitor the beam energy (Klein 
et al., 2009; Kutcher et al., 1994). The routine measurement should verify that the PDD curve does 
not deviated from the commissioning result. Tissue phantom ratio (TPR) is introduced as a 
simplified version of PDD to describe the changes in dose with depth that usually measured at two 
depth points in water (Purdy, 1977). AAPM TG-51 and IAEA TRS 398 have provided guidelines 
to perform the TPR measurement. The tolerance level of beam energy is ± 1% of the PDD (Klein 
et al., 2009; Smith et al., 2017). 
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Most of the daily devices (will be explained further in Section 3.3.2) are now designed 
capable to measure other beam parameters besides dose output including the beam flatness, the 
beam symmetry and the energy constancy. The daily results of the parameters can be monitored 
daily and verified against the monthly standard methods.  
 
2.2.2   Multileaf collimator (MLC) radiation shaping 
 
IMRT delivers highly conformal and complex dose distributions that utilise dynamic movement 
of the MLCs. The radiation dose is modulated to the target at different parts of target area. The 
dose is delivered with MLCs are continuously changing the shape without any beam hold-off in 
between the irradiation. In IGART, MLCs adjustments are the most common means to adapt the 
shape and size of tumours during the course of treatment (Yan, 2008). The study conducted by 
Wu et al. has shown that modifying treatment plan using MLCs resulted in better dose efficacy in 
terms of dose distribution in the target and in normal tissue of prostate and head and neck cancer 
treatment (Wu et al., 2006). Besides, the recent study conducted by Keall et al. also used the 
method of adjusting the leaf position to optimally align the treatment beam with real-time target 
position. Eight prostate stereotactic abative body radiotherapy (SABR) patients were treated with 
this real-time technique (Keall et al., 2018). 
For the complex treatment fields, dose delivery throughout the target volume is sensitive 
to leaf positioning and leaf transmissions. This is supported by several publications that 
documented the impact of leaf positioning accuracy on the delivered IMRT fields such as 
(Bayouth & Morrill, 2003) and (LoSasso, 2008). Therefore, it is essential to routinely monitor the 
MLC performance to ensure the accuracy and reproducibility of the leaf motion in every fraction 
of the treatment plan (LoSasso et al., 2001). 
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  According to TG-142 (Klein et al., 2009), the MLC performance tests should be 
conducted on weekly and monthly basis by delivering a beam that requires the MLCs to move 
dynamically, such as the picket fence test described by (LoSasso et al., 2001). Conventionally, the 
test used to assess leaf positional accuracy qualitatively by the matching of sequential segments 
and leaf transmission during the beam modulated by dynamic MLCs. For example, TG-142 
suggested a careful examination of the image acquired by static film or EPID is performed to 
assess the MLC performance. The prescriptions of picket fence test is further explained in Section 
3.4.1. On a monthly test, the leaf position accuracy test is expanded to account for gantry rotation 
which may affect leaf motion due to gravitational effects imposed on the leaf carriage system. TG 
142 suggested MLC positional tolerance for monthly test is ± 1 mm. This is agreed by Budgell et 
al. where the accuracy of leaf positioning should be better than 1 mm to ensure accurate dose 
delivery of IMRT fields (Budgell et al., 2000b)   
 
2.2.3   CBCT image guidance system 
 
IGART highly relies on imaging guidance during the fractional beam delivery. A CBCT based 
image guidance is used for imaging and positioning. However, positioning accuracy is beyond the 
scope of this study. Thus, an effort should be taken in developing a QAP for the imaging device 
to ensure that the imaging performance characteristics do not differ from the established baseline 
at the time of commissioning (Klein et al., 2009).  AAPM TG-179 (Bissonnette et al., 2012) has 
suggested several aspects of QAP (test and tolerance) to determine the performance of the CBCT 
system with respect to IGART requirements, such as image quality and accuracy of CT numbers. 
Image quality measurements in that report basically followed TG-74 (Whiting, 2002) and TG-142 
(Klein et al., 2009). TG-179 recommends a set of image quality tests that is performed initially on 
a monthly basis, and ultimately on a semi-annual basis, after the stability of CBCT system has 
